HOME >> BIOLOGY >> NEWS
CSHL shows correcting RNA splicing may help treat spinal muscular atrophy

Cold Spring Harbor, New York -- RNA splicing antisense technology studied at Cold Spring Harbor Laboratory (CSHL) effectively corrected an mRNA splicing defect found in spinal muscular atrophy (SMA) patients, and is now ready to be tested in mouse models. "SMA patients who suffer from motor-neuron degeneration may benefit from our ability to correct the mRNA splicing defect that makes their SMN2 genes only partially functional," suggested CSHL Professor Adrian Krainer, Ph.D.

RNA splicing antisense technology allows researchers to influence the ultimate structure and function of proteins. Proteins are synthesized from instructions coded in the DNA through a multi-step process that includes RNA splicing. Information stored in the DNA of genes is transcribed into immature "pre-messenger RNAs" (pre-mRNAs), pre-mRNAs are then spliced into mature "messenger RNAs" (mRNAs), and finally, mRNAs are translated into proteins. In humans and most other organisms, the splicing process thus ensures proper protein production.

"Targeting the splicing process is a promising strategy for finding new medicines to treat SMA, and possibly other diseases," said Marcus Rhoades, Ph.D. of the National Institute of General Medical Sciences, which partially supported Krainers research. "This work brings us one step closer to that goal."

The defect in SMN2 gene expression in SMA patients is at the level of pre-mRNA splicing, such that exon 7 tends to be left out of the mRNA that ultimately makes SMN protein. Several strategies have been pursued to increase the extent of exon 7 inclusion in the splicing of SMN2, for eventual use as therapeutics for SMA. The Krainer team, in collaboration with a team at Isis Pharmaceuticals, surveyed a large number of antisense oligonucleotides (ASOs) and found that some of these ASOs are able to correct the mRNA splicing defect in cultured cells from SMA patients. These powerful ASOs are identified by the Krainer team as
'"/>

Contact: Dagnia Zeidlickis
zeidlick@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
12-Mar-2007


Page: 1 2

Related biology news :

1. Clones on task serve greater good, evolutionary study shows
2. Research shows skeleton to be endocrine organ
3. An early ape shows its hand
4. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
5. Huntingtons disease study shows animal models on target
6. Research shows NPD1 protects a key component of vision
7. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
8. Chitin from lobster shell shows great healing and bio-stimulant properties
9. Study shows cane sugar, corn sweeteners have similar effects on appetite
10. New research shows vaginal bacteria vary among healthy women, need customized treatment
11. Global warming is evaporating Arctic ponds, new study shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2018)... ... 20, 2018 , ... When designing a fluidic system for ... ensure what is designed can be manufactured reliably and cost effectively while meeting ... path design with specific focus on layered manifold technology. , Layered manifold technology ...
(Date:8/17/2018)... N.J. and LIEGE, Belgium (PRWEB) , ... ... ... Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider ... services including a number of targeted DNA methylation assays using pyrosequencing or ...
(Date:8/17/2018)... , ... August 16, 2018 , ... ... world’s first private cord blood bank to separate and store stem cells in ... Center, and Brian Sheehy, M.D. M.A. C.F.A., Founder and Managing Partner IsZo Capital, ...
Breaking Biology News(10 mins):
(Date:9/1/2018)... ... August 31, 2018 , ... Rudina Thanasi, ... of a proprietary biofield energy treated nutraceutical supplement used in combating inflammation and ... response and blood, as well as, organ-specific inflammation. The reported data is as ...
(Date:8/29/2018)... ... August 28, 2018 , ... Nanovis , an ... successful completion of a $5.5 million funding round managed by Commenda Securities. Key ... Capital, and Ellipsis Ventures. , “Our investment in Nanovis is consistent with our ...
(Date:8/29/2018)... ... August 28, 2018 , ... CEO and founder ... safety study performed on an allogeneic (donor derived) stem cell product for osteoarthritis ... conference in September. He is also the organizer of Breakout Session 4: ...
(Date:8/26/2018)... ... August 23, 2018 , ... ... engineers, and scientists from around the world, will host the 4th Annual Microbiology ... array of industries and disciplines, encompassing various research areas including medicine, agriculture, and ...
Breaking Biology Technology:
Cached News: